Healthcare Stocks – Viropharma Plunges On Lowered Outlook (VPHM, POZN, PFE, BIIB, ENDP, BDX)
Viropharma Inc (NASDAQ:VPHM) decreased 8.64% to $19.87. The posted first quarter net income of $20.0 million or 26 cents per share compared to $36.4 million or 40 cents per share in the prior year period. However, analysts’ estimated 42 cents per share. Revenue increased 7% to $135.8 million compared with analysts’ estimates of $148.8 million.
The companies now estimate to generate revenue in the range of $450 million to $500 million, from its previous forecast of $600 million to $660 million. Analysts are expecting $502.4 million.
POZEN Inc (NASDAQ:POZN) went down 2.70% to $6.47 after the Company reported first quarter sales. Total revenue was $4.5 million driven by royalty on sales of Treximet of $4.1 million and $0.4 million from royalty on sales of VIMOVO.
Pfizer Inc (NYSE:PFE) is down 0.13% to $22.86. The Company posted first quarter EPS of $0.58, beating the analyst estimate of $0.56. Revenue was $15.4 billion versus the consensus estimate of $15.47 billion. The Company expects adjusted EPS to be in the range $2.14-$2.24 on sales of $58-$60 billion for fiscal year 2012.
Biogen Idec Inc (NASDAQ:BIIB) declined 1.13% to $132.46 subsequent to the Company reported first quarter sales. Profit was $302.7 million or $1.25 per share versus $294.3 million or $1.20 per share in the prior year period. Revenue jumped 7.4% to $1.29 billion. However, analysts forecast earnings of $1.48 a share on revenue of $1.31 billion. Operating margin fell to 28.6% from 34.6%.
Endo Pharmaceuticals Holdings Inc (NASDAQ:ENDP) is down 0.97% to $34.80. The Company posted first quarter loss of $87.3 million or 75 cents per share compared to profit of $55.8 million or 46 cents per share in the prior year period. Revenue increased 23% to $691 million due to American Medical Systems acquisition. However, analysts projected $702 million. Gross margin declined 47.2% from 58.7%.
Becton, Dickinson and Co (NYSE:BDX) is down 0.43% to $78.11 after the Company released second quarter results. Net income was $291.03 million compared to $312.02 million in the previous year period. EPS was $1.39 compared to $1.38 per share in the prior year period. Revenues increased 3.6% to $1.99 billion. Total operating costs and expenses increased 6.9% to $1.58 billion.